Skip to Main Content

Paper Details

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial.
1
2023
ACS, Ezetimibe, LDL-C, Simvastatin, Vytorin, acute coronary syndrome, bempedoic acid, cholesterol, cholesterol ester, cholesterol ester transfer proteins, diabetes, ezetimibe, heart failure, kexin, low-density lipoprotein cholesterol, patients, polyvascular disease, renal dysfunction, simvastatin, statin, stroke, subtilisin, women
Author NameAffiliation
Robert P GiuglianoBrigham and Women's Hospital
  • 1 - 1

Datasets

Release 1.2